171 related articles for article (PubMed ID: 18423402)
1. Paraoxonase 1 (PON1) status in gastroesophageal malignancies and associated paraneoplastic syndromes - connection with inflammation.
Krzystek-Korpacka M; Boehm D; Matusiewicz M; Diakowska D; Grabowski K; Gamian A
Clin Biochem; 2008 Jul; 41(10-11):804-11. PubMed ID: 18423402
[TBL] [Abstract][Full Text] [Related]
2. Oxidative status and serum PON1 activity in beta-thalassemia minor.
Selek S; Aslan M; Horoz M; Gur M; Erel O
Clin Biochem; 2007 Mar; 40(5-6):287-91. PubMed ID: 17296173
[TBL] [Abstract][Full Text] [Related]
3. Respiratory insufficiency related to COPD accelerates systemic inflammation, under-nutrition, and angiogenesis in esophageal malignancies.
Krzystek-Korpacka M; Matusiewicz M; Diakowska D; Grabowski K; Neubauer K; Kustrzeba-Wojcicka I; Terlecki G; Gamian A
Exp Oncol; 2008 Mar; 30(1):75-80. PubMed ID: 18438346
[TBL] [Abstract][Full Text] [Related]
4. Activity of paraoxonase 1 (PON1) and its relationship to markers of lipoprotein oxidation in healthy Slovaks.
Sumegová K; Blazícek P; Waczulíková I; Zitnanová I; Duracková Z
Acta Biochim Pol; 2006; 53(4):783-7. PubMed ID: 17106515
[TBL] [Abstract][Full Text] [Related]
5. Serum paraoxonase and arylesterase activities in patients with lung cancer in a Turkish population.
Elkiran ET; Mar N; Aygen B; Gursu F; Karaoglu A; Koca S
BMC Cancer; 2007 Mar; 7():48. PubMed ID: 17362500
[TBL] [Abstract][Full Text] [Related]
6. PON1 status in haemodialysis patients and the impact of hepatitis C infection.
Horoz M; Aslan M; Selek S; Koylu AO; Bolukbas C; Bolukbas FF; Celik H; Erel O
Clin Biochem; 2007 Jun; 40(9-10):609-14. PubMed ID: 17335792
[TBL] [Abstract][Full Text] [Related]
7. Paraoxonase/arylesterase ratio, PON1 192Q/R polymorphism and PON1 status are associated with increased risk of ischemic stroke.
Can Demirdöğen B; Türkanoğlu A; Bek S; Sanisoğlu Y; Demirkaya S; Vural O; Arinç E; Adali O
Clin Biochem; 2008 Jan; 41(1-2):1-9. PubMed ID: 17920578
[TBL] [Abstract][Full Text] [Related]
8. Vitamin C attenuates hypochlorite-mediated loss of paraoxonase-1 activity from human plasma.
Kunes JP; Cordero-Koning KS; Lee LH; Lynch SM
Nutr Res; 2009 Feb; 29(2):114-22. PubMed ID: 19285602
[TBL] [Abstract][Full Text] [Related]
9. Baseline and salt-stimulated paraoxonase and arylesterase activities in patients with chronic liver disease: relation to disease severity.
Keskin M; Dolar E; Dirican M; Kiyici M; Yilmaz Y; Gurel S; Nak SG; Erdinc S; Gulten M
Intern Med J; 2009 Apr; 39(4):243-8. PubMed ID: 19402863
[TBL] [Abstract][Full Text] [Related]
10. Arylesterase and paraoxonase activity of paraoxonase (PON1) affected by ischemia in the plasma of patients with arterial occlusion of the lower limbs.
Kasprzak M; Iskra M; Majewski W; Wielkoszyński T
Clin Biochem; 2009 Jan; 42(1-2):50-6. PubMed ID: 18976644
[TBL] [Abstract][Full Text] [Related]
11. Serum paraoxonase and arylesterase activities in patients with epithelial ovarian cancer.
Camuzcuoglu H; Arioz DT; Toy H; Kurt S; Celik H; Erel O
Gynecol Oncol; 2009 Mar; 112(3):481-5. PubMed ID: 19101714
[TBL] [Abstract][Full Text] [Related]
12. Effects of caloric restriction and gender on rat serum paraoxonase 1 activity.
Thomàs-Moyà E; Gianotti M; Lladó I; Proenza AM
J Nutr Biochem; 2006 Mar; 17(3):197-203. PubMed ID: 16214326
[TBL] [Abstract][Full Text] [Related]
13. PON1 status is influenced by oxidative stress and inflammation in coronary heart disease patients.
Kotur-Stevuljevic J; Spasic S; Jelic-Ivanovic Z; Spasojevic-Kalimanovska V; Stefanovic A; Vujovic A; Memon L; Kalimanovska-Ostric D
Clin Biochem; 2008 Sep; 41(13):1067-73. PubMed ID: 18634772
[TBL] [Abstract][Full Text] [Related]
14. Paraoxonase and arylesterase activities in untreated dipper and non-dipper hypertensive patients.
Yildiz A; Gur M; Demirbag R; Yilmaz R; Akyol S; Aslan M; Erel O
Clin Biochem; 2008 Jul; 41(10-11):779-84. PubMed ID: 18355454
[TBL] [Abstract][Full Text] [Related]
15. Serum lipid profile paraoxonase and arylesterase activities in psoriasis.
Toker A; Kadi M; Yildirim AK; Aksoy H; Akçay F
Cell Biochem Funct; 2009 Apr; 27(3):176-80. PubMed ID: 19330810
[TBL] [Abstract][Full Text] [Related]
16. Paraoxonase 1 (PON1) organophosphate hydrolysis is not reduced in ALS.
Wills AM; Landers JE; Zhang H; Richter RJ; Caraganis AJ; Cudkowicz ME; Furlong CE; Brown RH
Neurology; 2008 Mar; 70(12):929-34. PubMed ID: 18347314
[TBL] [Abstract][Full Text] [Related]
17. Serum paraoxonase and arylesterase activities for the evaluation of patients with chronic hepatitis.
Aslan M; Horoz M; Nazligul Y; Bolukbas C; Bolukbas FF; Selek S; Aksoy N; Erel O
Int J Clin Pract; 2008 Jul; 62(7):1050-5. PubMed ID: 17887991
[TBL] [Abstract][Full Text] [Related]
18. Determination of oxygen derived free radicals producer (xanthine oxidase) and scavenger (paraoxonase1) enzymes and lipid parameters in different cancer patients.
Samra ZQ; Pervaiz S; Shaheen S; Dar N; Athar MA
Clin Lab; 2011; 57(9-10):741-7. PubMed ID: 22029190
[TBL] [Abstract][Full Text] [Related]
19. Effect of PON1 polymorphism on HDL antioxidant potential is blunted with aging.
Cherki M; Berrougui H; Isabelle M; Cloutier M; Koumbadinga GA; Khalil A
Exp Gerontol; 2007 Aug; 42(8):815-24. PubMed ID: 17532162
[TBL] [Abstract][Full Text] [Related]
20. CRP genetic polymorphism is associated with lymph node metastasis in thoracic esophageal squamous cell cancer.
Motoyama S; Miura M; Hinai Y; Maruyama K; Usami S; Saito H; Minamiya Y; Satoh S; Murata K; Suzuki T; Ogawa J
Ann Surg Oncol; 2009 Sep; 16(9):2479-85. PubMed ID: 19495883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]